Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease

BACKGROUND: Systems biology holds promise as a new approach to drug target identification and drug discovery against neglected tropical diseases. Genome-scale metabolic reconstructions, assembled from annotated genomes and a vast array of bioinformatics/biochemical resources, provide a framework for...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavali, Arvind K, Blazier, Anna S, Tlaxca, Jose L, Jensen, Paul A, Pearson, Richard D, Papin, Jason A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388006/
https://www.ncbi.nlm.nih.gov/pubmed/22540944
http://dx.doi.org/10.1186/1752-0509-6-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388006/
https://www.ncbi.nlm.nih.gov/pubmed/22540944
http://dx.doi.org/10.1186/1752-0509-6-27

Ejemplares similares